Nayzilam

Discussion in 'UCB Pharma' started by anonymous, Aug 23, 2019 at 4:59 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    How can I get job as a rep for this Launch?
    I was an Epilepsy rep, and want to get back to the Disease Area that I love.
    Is UCB hiring ?
     

  2. anonymous

    anonymous Guest

    You didn’t mention patient value in your post. That could be your problem.

    It’s like Beetlejuice. Say it three times and the fun begins.
     
  3. anonymous

    anonymous Guest

    what do you mean?
     
  4. anonymous

    anonymous Guest

    So what’s up with this launch? Hiring?
     
  5. anonymous

    anonymous Guest

    I wouldn’t jump for this. If we can’t get it out the door soon, Neurelis is going to kick our ass with their product.
     
  6. anonymous

    anonymous Guest

    Neurelis product has some performance issues but between Neurlis and Libervant this will be a tough sell.
     
  7. anonymous

    anonymous Guest

    May want to check where the bones are buried on Nayzilam. It’s not all sunshine and roses either.
     
  8. anonymous

    anonymous Guest

    the efficacy of nayzilam is marginal versus placebo. lucky it was even approved.
     
  9. anonymous

    anonymous Guest

    BS

    Nayzilam is great. Much better than that crappy Listerine strip called Liver-ass. My docs said he had a patient in the clinical study aspirate on that crap.

    UCB ROCKS
     
  10. anonymous

    anonymous Guest

    Nayzilam barely moves the needle:

    "Numerical differences in favor of NAYZILAM were observed on each of the components of the treatment success responder definition; termination of seizure(s) within 10 minutes after initial dose of study drug (80.6 versus 70.1%) and the absence of seizure recurrence between 10 minutes and 6 hours after the initial dose of study drug (58.2 versus 37.3%).

    Study 1 also evaluated the occurrence and time to next seizure after the initial blinded dose of study drug. A smaller proportion of NAYZILAM-treated patients experienced the next seizure within 24 hours after the initial blinded dose of study drug (37.3% versus 46.3%). NAYZILAM-treated patients experienced a statistically longer time-to-next-seizure than the placebo group (Figure 1)."
     
  11. anonymous

    anonymous Guest

    AND WHAT EFFICACY DATA YOU HAVE WITH YOUR LIVER-ASS-NT Listerine strip published????? Because all we are aware is of some little pharmacokinetic studies for which the results may be crooked!!! Answer that you midget Aquestive rep !!!
     
  12. anonymous

    anonymous Guest

    Fuck you UCB dogs! How is Briviact doing? LOL! That whole conversion target pigeon holed your shitty me too. Wait till SK comes and you will see all that market share GONE!!!
     
  13. anonymous

    anonymous Guest

    Hahaha. Good one. You'll get crushed by diazepam. Whether its Neurelis or Liber-Ass remains to be shown.
     
  14. anonymous

    anonymous Guest

     
  15. anonymous

    anonymous Guest

    Liver-assNT we are going to make you eat dirt!!!!
    Your strip is garbage.
    Look, Sunovion still hasn't gotten your apomorphine strip approved.
    Heard all sort of issues.
    Nayzilam is the KING, baby.
     
  16. anonymous

    anonymous Guest

    And what data you have Aquestive? None.

    Does Aquestive have a Board here in CafePharma???
    Nah. Too bad. It be fun to post on your Board, just like you do in ours.
    You are some Nasty people
     
  17. anonymous

    anonymous Guest

    So when are you guys kicking this dog to the curb called Nayzilam???
    Is not out yet, and probably will never be.
     
  18. anonymous

    anonymous Guest

    Somebody blew it on this launch. Probably been promoted to SVP of some made up value group.

    How do you pay $350M for an approved product and screw up the launch?

    Nice job UCB!
     
  19. anonymous

    anonymous Guest

    didn't you just bring in a new head of marketing a few months ago?
     
  20. anonymous

    anonymous Guest

    You guys are going end up like Belgian Waffles after facing the wrath of Aquestive. Got the BEST and GREATEST technology everrrrrrrr. We are going to Make Epilepsy GREAT AGAIN. Will sell LIbervant to every one that has a seizure. You can't compete against the Aquestive sales machine, you Belgian Waffles.